Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

dc.contributor.author	Stratmann, Svea
dc.contributor.author	Yones, Sara A.
dc.contributor.author	Mayrhofer, Markus
dc.contributor.author	Norgren, Nina
dc.contributor.author	Skaftason, Aron
dc.contributor.author	Sun, Jitong
dc.contributor.author	Smolińska, Karolina
dc.contributor.author	Komorowski, Jan
dc.contributor.author	Herlin, Morten Krogh
dc.contributor.author	Sundström, Christer
dc.contributor.author	Eriksson, Anna
dc.contributor.author	Höglund, Martin
dc.contributor.author	Palle, Josefine
dc.contributor.author	Abrahamsson, Jonas
dc.contributor.author	Jahnukainen, Kirsi
dc.contributor.author	Munthe-Kaas, Monica Cheng
dc.contributor.author	Zeller, Bernward
dc.contributor.author	Tamm, Katja Pokrovskaja
dc.contributor.author	Cavelier, Lucia
dc.contributor.author	Holmfeldt, Linda
dc.date.accessioned	2022-01-31T09:19:36Z
dc.date.available	2022-01-31T09:19:36Z
dc.date.created	2022-01-19T11:57:56Z
dc.date.issued	2021
dc.identifier.citation	Blood Advances. 2021, 5 (3), 900-912.
dc.identifier.issn	2473-9529
dc.identifier.uri	https://hdl.handle.net/11250/2975850
dc.language.iso	eng
dc.title	Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.pagenumber	900-912
dc.source.volume	5
dc.source.journal	Blood Advances
dc.source.issue	3
dc.identifier.doi	10.1182/bloodadvances.2020003709
dc.identifier.cristin	1984591
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1